Development of Quantitative System Toxicology (QST) approaches to improve the understanding of the safety of new medicines

Inicio / Programas UE / H2020 / IMI2-2015-06-01
Logo

(IMI2-2015-06-01) - DEVELOPMENT OF QUANTITATIVE SYSTEM TOXICOLOGY (QST) APPROACHES TO IMPROVE THE UNDERSTANDING OF THE SAFETY OF NEW MEDICINES

Programme: Horizon 2020 Framework Programme
Call: H2020-JTI-IMI2-2015-06-two-stage EU

Topic description

Specific Challenge:

Modeling is fundamental to drug development. But there is the need to develop innovative methodologies and practices to integrate the ‘omics analysis and network analysis with quantitative mechanism-based models to form a new approach to drug safety assessment. The emerging field of Quantitative Systems Pharmacology (QSP) seeks to address this methodological gap via the development of mathematical models that account for the mechanisms underlying the response of integrated biological systems at the level of target cells and organs.

Scope:

The scope of this proposal is to 1) develop Quantitative Systems Toxicology (QST) models for drug-induced toxicity with the focus on four different organ systems: Heart, Liver, Kidney and the Gastrointestinal (GI)-immune system, and 2) use this QST approach for the prediction of clinical toxicity using preclinical data.

Expected Impact:

The results of this action will help to address the needs of the toxicology community for more comprehensive coverage of mechanistic toxicity pathways from which to define a mechanism-based screening approach.

Keywords

Systems biology Toxicology Safety Pharmacology Biological systems analysis, modelling and simulat Bioinformatics

Tags

toxicology sciences biocomputing taxicology gastrointestinal-immune system heart systems biology modelling and simumation liver DNA and molecular computation big data mining user-friendly interface Quantitative and systems pharmacology in vitreo, molecular and mechanisitic toxicology translational bioinformatics data management and curation comparative medicines information systems preclinical safety bioinformatics data visualisation PBPK and Drug disposition modelling kidney data integration safety pharmacology

Non atopas a financiación que precisas?

Contacta con nos e cóntanos cal é o teu proxecto.